Mache dechanj, echanj stock jodi a
Stock quotes de 71229 konpayi nan tan reyèl.
Mache dechanj, echanj stock jodi a

Stock quotes

Stock quotes sou entènèt

Stock quotes istwa

Mache dechanj majiskil

Dividann Stock

Pwofi nan aksyon konpayi

Rapò finansye

Rating aksyon nan konpayi yo. Ki kote envesti lajan?

Arrowhead Pharmaceuticals, Inc. bouchon mache

Volim nan komès stock Arrowhead Pharmaceuticals, Inc. jodi a ak istwa a nan lèt majiskil nan Arrowhead Pharmaceuticals, Inc. Depi nan kòmansman an nan komès nan ARWR aksyon sou echanj la machandiz.
Add to widgets
Te ajoute nan widgets

Arrowhead Pharmaceuticals, Inc. lèt majiskil

Jodi a lèt majiskil sou mache a nan Arrowhead Pharmaceuticals, Inc. se 4 199 178 752 US dola.
+367 170 816 $ (+9.58%)
chanjman nan lèt majiskil depi yè

Arrowhead Pharmaceuticals, Inc. majiskil an dola jodi an. Arrowhead Pharmaceuticals, Inc. lèt majiskil, sa vle di kantite aksyon eksepsyonèl miltipliye pa pri a pataje, yo montre. Sa a se enfòmasyon referans sou majiskil Arrowhead Pharmaceuticals, Inc.. Arrowhead Pharmaceuticals, Inc. mache kap jodi a se $ 4 199 178 752.

Arrowhead Pharmaceuticals, Inc. volim nan komès

Jodi a volim nan komès de aksyon Arrowhead Pharmaceuticals, Inc. montan 878 829 US dola.
-278 938 $ (-24.09%)
chanjman nan volim nan komès depi yè

Arrowhead Pharmaceuticals, Inc. te fè kòmès sou echanj valè diferan. Tablo chak jou nan Arrowhead Pharmaceuticals, Inc. komès volim prezante sou sit entènèt nou an. Arrowhead Pharmaceuticals, Inc. komès sou entènèt kenbe nan anpil mache estòk, nou montre volim total Arrowhead Pharmaceuticals, Inc. komès pa jou. Arrowhead Pharmaceuticals, Inc. majiskil te ogmante pa $ 367 170 816.

Montre:
Pou

Arrowhead Pharmaceuticals, Inc. mache bouchon tablo

Arrowhead Pharmaceuticals, Inc. mache kap kap tablo pa ane. 15.46% pa semèn - yon chanjman nan lèt majiskil sou mache Arrowhead Pharmaceuticals, Inc.. 0% - Arrowhead Pharmaceuticals, Inc. chanjman kapitalizasyon mache pou ane a. Arrowhead Pharmaceuticals, Inc. majiskil ap grandi chak jou nan dola ameriken.

Semèn Mwa 3 mwa Ane 3 zan

Arrowhead Pharmaceuticals, Inc. Istwa kapitalizasyon

Dat Kapitalizasyon
Kapitalizasyon (mache lèt majiskil) se valè sou mache a tout aksyon nan konpayi te fè kòmès sou echanj la machandiz. Mache lèt majiskil egal a pri de aksyon miltipliye pa kantite de aksyon eksepsyonèl.
03/05/2023 4 199 178 752 $
02/05/2023 3 832 007 936 $
01/05/2023 3 864 500 736 $
28/04/2023 3 769 729 536 $
27/04/2023 3 797 348 864 $
26/04/2023 3 664 668 672 $
25/04/2023 3 637 050 112 $

Arrowhead Pharmaceuticals, Inc. tablo volim

Semèn Mwa 3 mwa Ane 3 zan

Arrowhead Pharmaceuticals, Inc. done istwa volim

Dat Volim (24h)
Volim komèsyal de aksyon Arrowhead Pharmaceuticals, Inc. se kantite total tout tranzaksyon ak aksyon ARWR achte ak vann pandan dat la chwazi a.
03/05/2023 878 829 $
02/05/2023 1 157 767 $
01/05/2023 296 761 $
28/04/2023 191 198 $
27/04/2023 609 939 $
26/04/2023 430 082 $
25/04/2023 3 609 240 $

Arrowhead Pharmaceuticals, Inc. majiskil nan 03/05/2023 egal a 4 199 178 752 dola ameriken. Arrowhead Pharmaceuticals, Inc. mache majiskil nan 02/05/2023 egal a 3 832 007 936 dola ameriken. Sou 01/05/2023, Arrowhead Pharmaceuticals, Inc. lèt majiskil mache a te $ 3 864 500 736. Arrowhead Pharmaceuticals, Inc. lèt majiskil sou mache a se $ 3 769 729 536 nan 28/04/2023.

Sou 27/04/2023, Arrowhead Pharmaceuticals, Inc. lèt majiskil mache a te $ 3 797 348 864. Arrowhead Pharmaceuticals, Inc. majiskil nan 26/04/2023 montan pou 3 664 668 672 dola ameriken. Arrowhead Pharmaceuticals, Inc. majiskil egal a 3 637 050 112 dola ameriken nan 25/04/2023.

Lèt majiskil Arrowhead Pharmaceuticals, Inc. jodi a se 4 199 178 752 $. Kapitalizasyon sou mache a nan Arrowhead Pharmaceuticals, Inc. te chanje a +9.58% konpare ak yè. Volim komèsyal de aksyon ARWR nan Arrowhead Pharmaceuticals, Inc. nan dènye jou komès montan pou 878 829 $. Volim komèsyal de aksyon de Arrowhead Pharmaceuticals, Inc. chanje pou -24.0928% konpare ak jou komès anvan an.

Pri a de aksyon Arrowhead Pharmaceuticals, Inc.

Finans Arrowhead Pharmaceuticals, Inc.